Literature DB >> 20827453

[Anaesthesia in patients with maple syrup urine disease. Case report and perioperative anaesthetic management].

P Haberstich1, C H Kindler, M Schürch.   

Abstract

Maple syrup urine disease is a rare autosomal-recessive metabolic disorder caused by a deficit of oxidative decarboxylation of branched-chain amino acids. First symptoms appear in the neonatal period. Without treatment the disease is characterized by rapid progression of neurological symptoms. During stressful situations, such as infection or surgery, patients may experience severe ketoacidosis, rapid neurological deterioration and hypoglycemia. The perioperative management of a 26-year-old man with maple syrup urine disease is described, a review of the disease is given and anaesthesia-related implications are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827453     DOI: 10.1007/s00101-010-1762-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  7 in total

1.  Population pharmacokinetics of propofol for target-controlled infusion (TCI) in the elderly.

Authors:  J Vuyk; T Schnider; F Engbers
Journal:  Anesthesiology       Date:  2000-12       Impact factor: 7.892

2.  A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance.

Authors:  J H MENKES; P L HURST; J M CRAIG
Journal:  Pediatrics       Date:  1954-11       Impact factor: 7.124

3.  Anaesthetic management in maple syrup urine disease.

Authors:  S Kahraman; M Ercan; O Akkuş; O Erçelen; K Erdem; T Coşkun
Journal:  Anaesthesia       Date:  1996-06       Impact factor: 6.955

4.  Newborn screening fact sheets.

Authors:  Celia I Kaye; Frank Accurso; Stephen La Franchi; Peter A Lane; Northrup Hope; Pang Sonya; Schaefer G Bradley; Lloyd-Puryear Michele A
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

5.  Perioperative management of a patient with maple syrup urine disease.

Authors:  D Fuentes-Garcia; L Falcon-Arana
Journal:  Br J Anaesth       Date:  2009-01       Impact factor: 9.166

6.  Diagnosis and treatment of maple syrup disease: a study of 36 patients.

Authors:  D Holmes Morton; Kevin A Strauss; Donna L Robinson; Erik G Puffenberger; Richard I Kelley
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

7.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

Authors:  C F Minto; T W Schnider; T D Egan; E Youngs; H J Lemmens; P L Gambus; V Billard; J F Hoke; K H Moore; D J Hermann; K T Muir; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.